Clinical and neuroimaging correlations in patients with chronic cerebrovascular disease and type 2 diabetes mellitus

DOI: https://doi.org/10.29296/25877305-2023-04-11
Issue: 
4
Year: 
2023

M. Belokopytova(1); Associate Professor I. Dolgova(1); MD; Professor V. Baturin(1); MD; I. Grigoryants(2)
1-Stavropol State Medical University
2-City Clinical Hospital Three, Stavropol

A comprehensive examination was made in 81 patients with chronic cerebrovascular disease (CVD) concurrent with type 2 diabetes mellitus. The patients were divided into 3 groups: 1) patients with mild cognitive impairment (CI) (Study Group 1); 2) patients with moderate CI (Study Group 2); 3) patients without CI (a comparison group). The investigators studied the neuroimaging structure of the brain substance (BS) and the state of the brachiocephalic vessels. The study showed that the morphofunctional changes in the brain were most pronounced in moderate CI Group 2, which confirmed the association between the severity of clinical manifestations of CVD and atherosclerotic lesions of the cerebral vessels and degenerative changes in the BS. Analysis of MMSE and MoCA scores indicated statistically significant differences between the indicators of the comparison group and the study groups, as well as between those of Groups 1 and 2. There were statistically significant differences in the incidence of postischemic subcortical cysts in the brain between Group 2 and the comparison group, as well as between Groups 1 and 2.
Keywords: 
neurology
cerebrovascular disorders
type 2 diabetes mellitus
cognitive impairment
neuroimaging.

References: 
  1. Батурина М.В., Долгова И.Н., Хыбыртова М.Р., и др. Клинико-нейроиммуннологические корреляции при хронической ишемии мозга. Медицинский вестник Северного Кавказа. 2018; 1 (13): 110–1 [Baturina M.V., Dolgova I.N., Hibirtova M.R. et al. Clinical-neuromymonnological correlations in chronic brain ischemia. Medical News of North Caucasus. 2018; 1 (13): 110–1 (in Russ.)]. DOI: 10.14300/mnnc.2018.13031
  2. Антонова К.В., Танашян М.М., Максимова М.Ю. и др. Гликемический контроль у больных с цереброваскулярными заболеваниям и сахарным диабетом 2 типа. Клиническая фармакология и терапия. 2016; 25 (5): 40–4 [Antonova K.V., Tanashyan M.M., Maksimova M. Y.u. et al. Glycemic control in patients with cerebrovascular diseases and type 2 diabetes mellitus. Clinical Pharmacology and Therapy. 2016; 25 (5): 40–4 (in Russ.)].
  3. Коценко Ю.И., Статинова Е.А. Особенности когнитивных функций у больных с цереброваскулярными заболеваниями при сахарном диабете 2 типа. Университетская клиника. 2021; 4 (41): 86–93 [Kotsenko Yu.I., Statinova E.A. Features of cognitive functions in patients with cerebvascular diseases with diabetes mellitus type 2. University Clinic. 2021; 4 (41): 86–93 (in Russ.)]. DOI: 10.26435/UC.V0I4(41).671
  4. Танашян М.М., Суркова Е.В., Антонова К.В. и др. Сахарный диабет 2-го типа и когнитивные функции у пациентов с хроническими цереброваскулярными заболеваниями. Тер арх. 2021; 93 (10): 1179–85 [Tanashyan M.M., Surkova E.V.., Antonova KV. Et al. Type 2 diabetes and cognitive functions in patients with chronic cerebrovascular diseases. Ter Arkh. 2021; 93 (10): 1179–85 (in Russ.)]. DOI: 10.26442/00403660.2021.10.201108
  5. Шишкова В.Н., Адашева Т.В. Цереброваскулярные заболевания у пациентов с сахарным диабетом 2 типа. Журнал неврологии и психиатрии им. С.С. Корсакова. 2021; 121 (6): 114–8 [Shishkova V.N., Adasheva T.V. Cerebrovascular disease in patients with type 2 diabetes mellitus. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2021; 121 (6): 114–8 (in Russ.)]. DOI: 10.17116/jnevro2021121061114
  6. Stehouwer C.D.A. Microvascular Dysfunction and Hyperglycemia: A Vicious Cycle With Widespread Consequences. Diabetes. 2018; 67 (9): 1729–41. DOI: 10.2337/dbi17-0044
  7. Menyailo G.S., Tessier D.M. Diabetes, Dementia and Hypoglycemia. Can J Diabetes. 2016; 40 (1): 73–6. DOI: 10.1016/j.jcjd.2015.09.006
  8. Nanayakkara N., Curtis A.J., Heritier S. et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia. 2021; 64 (2): 275–87. DOI: 10.1007/s00125-020-05319-w
  9. Хабибулина М. Церебральная гемодинамика у молодых женщин с артериальной гипертензией и эстрогендефицитом. Врач. 2017; 3: 55–9 [Khabibulina M. Cerebral hemodynamics in young women with hypertension and estrogen deficiency. Vrach. 2017; 3: 55–9 (in Russ.)].
  10. Хабибулина М. Церебральная гемодинамика при артериальной гипертензии и андрогенодефиците. Врач. 2018; 29 (4): 26–32 [Khabibulina M. Cerebral hemodynamics in hypertension and androgen deficiency. Vrach. 2018; 29 (4): 26–32 (in Russ.)]. DOI: 10.29296/25877305-2018-04-04
  11. Дедов Д.В., Иванов А.П., Эльгардт И.А. Влияние электромеханического ремоделирования сердца на развитие фибрилляции предсердий у больных ИБС и артериальной гипертонией. Российский кардиологический журнал. 2011; 16 (4): 13–8 [Dedov D.V., Ivanov A.P., Elgardt I.A. Effect of electromechanical remodelling of the heart on the development of atrial fibrillation in patients with CHD and arterial hypertension. Rossijskij kardiologicheskij zhurnal. 2011; 16 (4): 13–8 (in Russ.)].
  12. Поспелова М.Л., Алексеева Т.М., Рыжкова Д.В. и др. Состояние когнитивных функций и перфузии головного мозга при хронической ишемии мозга на фоне асимптомного каротидного атеросклероза. Современные проблемы науки и образования. 2020; 6: 182 [Pospelova M.L., Alekseeva T.M., Ryzhkova D.V. et al. The state of cognitive functions and brain perfusion in chronic brain ischemia against the background of asymptomatic carotid atherosclerosis. Modern problems of science and education. 2020; 6: 182 (in Russ.)]. DOI: 10.17513/spno.30446